Zevra Therapeutics Inc. (ZVRA) Insider Trading
- $537,095.83
- $1,737,053.42
- Feb. 3, 2026
- Joshua Schafer
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 3, 2026 | Insider | 10,500 | $9.19 | Sell | $96,495.00 | |
| Feb. 3, 2026 | SVP | 3,000 | $9.18 | Sell | $27,540.00 | |
| Feb. 2, 2026 | CEO | 91,000 | $9.38 | Sell | $853,580.00 | |
| Jan. 30, 2026 | Insider | 3,375 | $8.83 | Sell | $29,801.25 | |
| Jan. 30, 2026 | Insider | 4,533 | $8.83 | Sell | $40,026.39 | |
| Jan. 30, 2026 | SVP | 1,750 | $8.82 | Sell | $15,435.00 | |
| Sept. 12, 2025 | Director | 3,175 | $7.79 | Buy | $24,733.25 | |
| Aug. 19, 2025 | Director | 5,000 | $9.16 | Buy | $45,800.00 | |
| March 28, 2025 | Director | 300 | $7.84 | Buy | $2,352.00 | |
| March 19, 2025 | Director | 10,000 | $7.96 | Buy | $79,600.00 | |
| Feb. 13, 2025 | EVP | 10,500 | $7.86 | Sell | $82,530.00 | |
| Feb. 13, 2025 | SVP | 3,000 | $7.86 | Sell | $23,580.00 | |
| Feb. 13, 2025 | CFO | 11,000 | $7.86 | Sell | $86,460.00 | |
| Feb. 13, 2025 | CEO | 61,273 | $7.86 | Sell | $481,605.78 | |
| Oct. 11, 2024 | Director | 500 | $7.92 | Buy | $3,960.00 | |
| July 17, 2024 | CFO | 2,000 | $6.77 | Buy | $13,540.00 | |
| July 16, 2024 | Director | 10,000 | $6.81 | Buy | $68,100.00 | |
| July 12, 2024 | Director | 10,000 | $5.87 | Buy | $58,700.00 | |
| Sept. 6, 2023 | CFO | 1,000 | $4.96 | Buy | $4,960.00 | |
| Sept. 5, 2023 | Director | 10,000 | $5.13 | Buy | $51,300.00 | |
| Sept. 5, 2023 | EVP | 500 | $5.13 | Buy | $2,565.00 | |
| June 23, 2023 | Director | 275 | $5.95 | Buy | $1,636.25 | |
| June 9, 2023 | Director | 325 | $5.52 | Buy | $1,794.00 | |
| May 30, 2023 | Director | 400 | $5.11 | Buy | $2,044.00 | |
| May 18, 2023 | Director | 10,000 | $5.04 | Buy | $50,400.00 | |
| May 18, 2023 | CFO | 2,740 | $4.95 | Buy | $13,563.00 | |
| March 17, 2023 | Director | 519 | $4.82 | Buy | $2,501.58 | |
| March 14, 2023 | EVP | 2,000 | $4.61 | Buy | $9,220.00 | |
| March 10, 2023 | SVP | 1,200 | $4.14 | Buy | $4,968.00 | |
| March 10, 2023 | CFO | 1,725 | $4.15 | Buy | $7,158.75 | |
| March 9, 2023 | CEO | 10,000 | $4.20 | Buy | $42,000.00 | |
| March 9, 2023 | Director | 11,000 | $4.20 | Buy | $46,200.00 |
Insiders are both buying and selling Zevra Therapeutics Inc. stock.
The insider traders at Zevra Therapeutics Inc. are: John B Bode, R. Laduane Clifton, Joshua Schafer, Corey Michael Watton, Timothy J Sangiovanni, Neil F Mcfarlane, Richard W Pascoe, Matthew R Plooster, Adrian W Quartel, Tamara A Favorito, Tamara A Seymour, and Thomas Anderson
The most active insider trader at Zevra Therapeutics Inc. is John B Bode with 5 trades.
Neil F Mcfarlane has sold the most Zevra Therapeutics Inc. stock with a total value of $2,188,765.78.
John B Bode has bought the most Zevra Therapeutics Inc. stock with a total value of $331,600.00.
The most recent insider trade for Zevra Therapeutics Inc. was on Feb. 3, 2026.
The single biggest insider buy for Zevra Therapeutics Inc. was from John B Bode with a total value of $79,600.00 on March 19, 2025.
The single biggest insider sell for Zevra Therapeutics Inc. was from Neil F Mcfarlane with a total value of $853,580.00 on Feb. 2, 2026.